ondero Met

```html

Introduction to ondero Met

ondero Met is a combination medication available in tablet form, primarily used for managing type 2 diabetes. It combines linagliptin and metformin to help control blood sugar levels in adults.

Composition of ondero Met

ondero Met contains two active ingredients: linagliptin and metformin. Linagliptin works by increasing insulin release from the pancreas and decreasing glucagon levels, while metformin reduces glucose production in the liver and improves insulin sensitivity.

Uses of ondero Met

• Management of type 2 diabetes
• Helps control high blood sugar levels
• Improves insulin sensitivity

Side effects of ondero Met

• Common side effects: nausea, diarrhea, stomach upset
• Linagliptin side effects: runny nose, sore throat, cough
• Serious side effects: low blood sugar, lactic acidosis, pancreatitis

Precautions of ondero Met

Use ondero Met with caution if you have kidney or liver problems. Be aware of the risk of lactic acidosis with metformin and pancreatitis with linagliptin. Follow your healthcare provider's instructions and report any unusual symptoms immediately.

How to Take ondero Met

ondero Met is typically taken as a tablet. Metformin is usually taken at a dose of 500 mg to 1000 mg two to three times a day with meals, while linagliptin is taken at a dose of 5 mg once daily. Follow your doctor's advice for the correct dosage and administration.

Conclusion of ondero Met

ondero Met, a combination of linagliptin and metformin, is an effective medication for managing type 2 diabetes. It is manufactured to provide a comprehensive approach to diabetes management by controlling blood sugar levels. Always follow your healthcare provider's instructions for optimal results.

```